Supernus Pharmaceuticals, Inc. (SUPN)
29.72
+0.52
(+1.78%)
USD |
NASDAQ |
Nov 13, 16:00
29.30
-0.42
(-1.41%)
After-Hours: 19:59
Supernus Pharmaceuticals Shareholders Equity (Quarterly) : 1.062B for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 1.062B |
| June 30, 2026 | 1.031B |
| March 31, 2026 | 1.077B |
| December 31, 2025 | 1.062B |
| September 30, 2025 | 1.050B |
| June 30, 2025 | 1.064B |
| March 31, 2025 | 1.031B |
| December 31, 2024 | 1.036B |
| September 30, 2024 | 1.007B |
| June 30, 2024 | 957.45M |
| March 31, 2024 | 929.17M |
| December 31, 2023 | 921.52M |
| September 30, 2023 | 912.19M |
| June 30, 2023 | 919.91M |
| March 31, 2023 | 912.15M |
| December 31, 2022 | 886.20M |
| September 30, 2022 | 852.80M |
| June 30, 2022 | 841.43M |
| March 31, 2022 | 828.45M |
| December 31, 2021 | 815.85M |
| September 30, 2021 | 810.47M |
| June 30, 2021 | 785.58M |
| March 31, 2021 | 754.44M |
| December 31, 2020 | 744.86M |
| September 30, 2020 | 708.88M |
| Date | Value |
|---|---|
| June 30, 2020 | 665.97M |
| March 31, 2020 | 613.38M |
| December 31, 2019 | 595.43M |
| September 30, 2019 | 557.26M |
| June 30, 2019 | 522.90M |
| March 31, 2019 | 480.02M |
| December 31, 2018 | 453.02M |
| September 30, 2018 | 421.94M |
| June 30, 2018 | 390.49M |
| March 31, 2018 | 351.87M |
| December 31, 2017 | 267.48M |
| September 30, 2017 | 251.66M |
| June 30, 2017 | 229.40M |
| March 31, 2017 | 206.06M |
| December 31, 2016 | 191.76M |
| September 30, 2016 | 173.37M |
| June 30, 2016 | 110.22M |
| March 31, 2016 | 97.11M |
| December 31, 2015 | 88.01M |
| September 30, 2015 | 109.44M |
| June 30, 2015 | 71.82M |
| March 31, 2015 | 63.75M |
| December 31, 2014 | 71.35M |
| September 30, 2014 | 66.12M |
| June 30, 2014 | 33.37M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 637.11M |
| Prestige Consumer Healthcare, Inc. | 1.945B |
| Structure Therapeutics, Inc. | 1.222B |
| Corcept Therapeutics, Inc. | 833.74M |
| Veru, Inc. | 28.38M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.398B |
| Total Liabilities (Quarterly) | 335.21M |
| Debt to Equity Ratio | 0.0341 |
| Current Ratio | 2.492 |
| Net Debt Paydown Yield | -0.04% |